S

SWK Holdings Corp
NASDAQ:SWKH

Watchlist Manager
SWK Holdings Corp
NASDAQ:SWKH
Watchlist
Price: 14.09 USD -2.49% Market Closed
Market Cap: 172.6m USD

SWK Holdings Corp
Other

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SWK Holdings Corp
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
S
SWK Holdings Corp
NASDAQ:SWKH
Other
-$50k
CAGR 3-Years
82%
CAGR 5-Years
N/A
CAGR 10-Years
35%
LM Funding America Inc
NASDAQ:LMFA
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A-Mark Precious Metals Inc
NASDAQ:AMRK
Other
-$1.2m
CAGR 3-Years
41%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
FlexShopper Inc
NASDAQ:FPAY
Other
-$1.7m
CAGR 3-Years
-44%
CAGR 5-Years
-57%
CAGR 10-Years
9%
California First Leasing Corp
OTC:CFNB
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Standard Premium Finance Holdings Inc
OTC:SPFX
Other
-$116.2k
CAGR 3-Years
-33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

SWK Holdings Corp
Glance View

Market Cap
172.1m USD
Industry
Financial Services

SWK Holdings Corp. is engaged in the business of financial and asset management in the field of pharmaceutical. The company is headquartered in Dallas, Texas and currently employs 35 full-time employees. The firm is focused on providing various capital solutions to a range of life science companies, institutions and inventors. The firm operates through two segments: Finance Receivables and Pharmaceutical Development. Its Finance Receivables segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. In addition, through its wholly owned subsidiary, SWK Advisors LLC, it provides non-discretionary investment advisory services to institutional clients in separately managed accounts to similarly invest in life science finance. Through its subsidiary, Enteris BioPharma, Inc., its Pharmaceutical Development segment offers formulation solutions built around its oral drug delivery technology, the Peptelligence platform.

SWKH Intrinsic Value
14.12 USD
Fairly Valued
Intrinsic Value
Price
S

See Also

What is SWK Holdings Corp's Other?
Other
-50k USD

Based on the financial report for Dec 31, 2024, SWK Holdings Corp's Other amounts to -50k USD.

What is SWK Holdings Corp's Other growth rate?
Other CAGR 10Y
35%

Over the last year, the Other growth was 99%. The average annual Other growth rates for SWK Holdings Corp have been 82% over the past three years , and 35% over the past ten years .

Back to Top